» Authors » Tatsuhiro Yamazaki

Tatsuhiro Yamazaki

Explore the profile of Tatsuhiro Yamazaki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 66
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsumoto K, Kato H, Itoi T, Kitano M, Hara K, Kuwatani M, et al.
Endoscopy . 2024 Oct; PMID: 39454635
Endoscopic ultrasonography (EUS)-guided ethanol injection (EI) has recently been introduced as one of the management strategies for pancreatic neuroendocrine neoplasms (PNENs); however, its role as a surgical alternative is unclear....
2.
Fujii Y, Uchida D, Sato R, Obata T, Akihiro M, Miyamoto K, et al.
Sci Rep . 2024 Sep; 14(1):22441. PMID: 39341885
Rapid on-site cytopathology evaluation (ROSE) has been considered an effective method to increase the diagnostic ability of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA); however, ROSE is unavailable in most institutes...
3.
Oda T, Tsutsumi K, Obata T, Ueta E, Kikuchi T, Ako S, et al.
Mol Ther Oncol . 2024 Apr; 32(1):200765. PMID: 38596294
Gallbladder cancer incidence has been increasing globally, and it remains challenging to expect long prognosis with the current systemic chemotherapy. We identified a novel nucleic acid-mediated therapeutic target against gallbladder...
4.
Obata T, Tsutsumi K, Ueta E, Oda T, Kikuchi T, Ako S, et al.
Mol Ther Nucleic Acids . 2023 Dec; 34:102054. PMID: 38111913
Gemcitabine is an effective chemotherapeutic agent for biliary tract cancers (BTCs), including gallbladder cancer (GBC) and cholangiocarcinoma (CCA). However, few other effective agents are currently available, particularly for GEM-refractory BTCs....
5.
Terasawa H, Matsumoto K, Tanaka T, Tomoda T, Ogawa T, Ishihara Y, et al.
Pancreatology . 2023 Nov; 23(8):988-995. PMID: 37951728
Background: EUS-FNA/B for pancreatic ductal adenocarcinoma (PDAC) is generally considered to be safe; however, while the incidence is low, there are occurrences of complications. Among these complications, there are serious...
6.
Morimoto K, Matsumoto K, Obata T, Oda T, Miyamoto K, Matsumi A, et al.
Therap Adv Gastroenterol . 2023 Oct; 16:17562848231206980. PMID: 37900006
Background: Drainage exceeding 50% of total liver volume is a beneficial prognostic factor in patients with unresectable malignant hilar biliary obstruction (UMHBO). However, it is unclear what threshold percentage of...
7.
Horiguchi S, Matsumoto K, Morimoto K, Matsumi A, Terasawa H, Fujii Y, et al.
Acta Med Okayama . 2023 Oct; 77(5):517-525. PMID: 37899263
We investigated the effect of modified FOLFIRINOX (mFFX) in unresectable pancreatic cancer by retrospectively analyzing the cases of 43 patients who underwent BRCA testing (germline, n=11; somatic, n=26; both germline...
8.
Miyamoto K, Matsumoto K, Obata T, Sato R, Matsumi A, Morimoto K, et al.
BMC Gastroenterol . 2023 Sep; 23(1):296. PMID: 37667224
Background: The sedation method used during double-balloon endoscopic retrograde cholangiopancreatography (DB-ERCP) differs among countries and/or facilities, and there is no established method. This study aimed to evaluate the efficacy of...
9.
Himei H, Kato H, Saragai Y, Fujii Y, Yamazaki T, Uchida D, et al.
Acta Med Okayama . 2023 Jun; 77(3):291-299. PMID: 37357630
We investigated the efficacy and safety of endoscopic plastic stent (PS) placement for hilar benign biliary strictures (BBSs) and compared cases with PS placement above (inside stent, IS) and across...
10.
Kuraoka S, Iwamuro M, Satomi T, Yamazaki T, Hamada K, Kono Y, et al.
Acta Med Okayama . 2023 Jun; 77(3):235-241. PMID: 37357624
Changes in hormone levels in patients with cancer cachexia after anamorelin administration have not been fully investigated. This study aimed to determine how anamorelin affects the endocrine system in patients...